Persistent Treatment-Emergent Central Sleep Apnea (TECSA) Following Hypoglossal Nerve Stimulation.

"Disclosure Philipp Arens received financial support from ImThera Inc. and Apnex Medical Inc. within the framework of research projects related to hypoglossal nerve stimulation therapy. Philipp Arens received a speaker’s fee for an invited talk on behalf of Inspire Medical Inc. and an honorarium for a surgical proctoring. He also reports personal fees from Verlag für Printmedien und PR, XM Consult, and RG Gesellschaft für Information und Organisation mbH, outside the submitted work. Prof. Dr. Thomas Penzel reports unrestricted study grants from Cidelec, grants for consultation and study from Bayer Healthcare, consultation for Philips, grants, personal fees from Löwenstein Medical, personal fees from Neuwirth, Jazz Pharma, Idorsia, National Sleep Foundation, Cerebra, consultation and devices for Sleepimage, outside the submitted work. He also owns shares of Advanced Sleep Research GmbH, The Siestagroup GmbH, Nukute. Other authors report no conflicts of interest in this work."

"This study was funded by the Charité – Universitätsmedizin Berlin."